Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating safety, efficacy, and pharmacokinetics of tafamidis in patients with transthyretin cardiac amyloidosis after orthotopic heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Cardiac Amyloidosis

Drugs mentioned

• Tafamidis (tafamidis)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Transthyretin Cardiac Amyloidosis | Phase 4 | Status: RECRUITING